Stockreport

Skye Bioscience Names Independent Director Paul Grayson as Chairman of the Board

Skye Bioscience, Inc.  (SKYE) 
PDF SAN DIEGO, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therape [Read more]